Organic dust exposures in animal feed operations has long been shown to be detrimental to the health of workers in these facilities 1,2. Experimental approaches to determining the factors present in these dusts that may be responsible for respiratory inflammation have yielded considerable data, particularly on the role of microbial products such as endotoxins (LPS) and proteoglycans, and others as potential causes of these lung problems 3,4. Such dust exposures however are often in the context of facilities with a variety of elevated gases such as ammonia and hydrogen sulfide, both of which have been implicated in causing lung problems or being immuno-modulatory 5,6.
Carbon dioxide (CO2) has often been overlooked despite significant data showing routine elevations of CO2 in animal feed operations 7 often as high as the OSHA 8hr time weighted average (TWA) limit of 5000 ppm,. CO2 at levels as low as 1000 ppm have been shown to induce cognitive changes in humans 8,9. Indeed, elevated CO2 is a broader problem, and common in many facilities such as schools 9, daycares 10,11, prisons 12, cars 13, airplanes 14, and many other locations 15.
Previously we have shown that innate immune responses to organic dust extracts were changed when co-exposed to CO2 at 5000 ppm 16. These changes were at the protein and mRNA levels and in most cases were indicative of enhanced inflammation. Subsequent to this study others showed that neutrophils were altered by similar levels of CO2 17. At present however these are the only studies we are aware of to address this issue in lung immunology. There have been several studies related to behavior 18 and at higher levels of CO2 where there is induction of hypercapnic acidosis in animals and cell cultures 19–21. Results for these latter studies have been somewhat mixed, particularly in situations of LPS exposure versus more complex challenges such as tobacco extracts 21,22. These studies also do not address CO2 at levels applicable to most work environments and crowded spaces 23,24.
The aims of the current study were to extend the previous co-exposure model to assess lower levels of CO2 exposure while at the same time testing both a defined single inflammatory stimuli (LPS) and a complex one (organic dust extracts). We hypothesize that the lung alters innate immune responses when presented with a combined exposure of an inflammatory agent and CO2 as low as 1000 ppm.
Methods
Organic Dust Extracts and Treatments
Organic dust extracts (HDE) were produced from settled dust samples collected from two separate swine confinement facilities in Nebraska. These dust extracts have been characterized previously for muramic acid, endotoxin, and protein25, and the bacterial composition has also been described26. Extracts were prepared by mixing 1 g dust with 10 ml HBSS (without calcium, Sigma, St. Louis, MS) and incubating for 1hr at room temperature before centrifugation twice, and subsequent filter sterilization through a Nalgene 0.2uM SFCA membrane syringe filter (ThermoFisher, Rochester, NY) as described previously 27. This results in a solution of approximately 0.105 g/ml dust that is stable at -20C or lower for at least a year or more. Dust extracts were given to mice at a final concentration of 12.5% vol/vol or 0.005 g/ml dust delivered in 40 ul dropwise to the nares, and mice allowed to inhale under light (1%) isoflurane anesthesia.
LPS from Escherichia coli 0111:B4 (lot 095M4163V, Sigma, St. Louis) was diluted in HyClone HBSS(1X) (HyClone Laboratories; Logan, UT) to 0.1 µg, and delivered in 40 ul to the nares, and mice allowed to inhale under light (1%) isoflurane anesthesia. Control groups were given 40 ul HBSS in the same manner under light anesthesia.
Animals
Six to seven week old female C57BL/6 mice were purchased from Charles River Laboratories (Montreal, Quebec, Canada). Mice were housed in standard cages in a controlled room with ambient temperature of 23oC +/- 2oC and a 12-hour light/dark cycle. Mice were fed standard laboratory chow and water ad libitum. Mice were acclimatized in their first week in facility for 2 hours per day for 5 days to plethysmography chambers (part 601-1425-001; DSI, Minneapolis, MN) ventilated by a Buxco Finepointe whole body plethysmography 4-site system (DSI, Minneapolis Minnesota). All intranasal treatments were given between 8:00–8:30AM to minimize any potential circadian rhythm differences between treatments. At end of the experiment mice were euthanized.
CO2 Delivery and Whole Body Plethysmography
All mice upon intranasal treatment were placed immediately into whole body plethysmography (WBP) chambers (DSI, Minneapolis, MN) for the duration of exposure under positive airflow of 5psi. The biasflow air consisted of either of room air (~ 500 ppm CO2), or air from tanks consisting of room air enriched for CO2 to 1000, or 5000 ppm CO2 (Praxair; Mississauga, Canada). Airflow was constant through the exposure period to prevent any accumulation of CO2 due to respiration from animals. Mice were provided with food and water in exposure chambers for the duration of exposures. CO2 readings of the treatment room provided an average ambient CO2 level of 430 ppm averaged over 8 using a Q-Trak Indoor Air Quality Monitor 7575 (TSI; Shoreview, MN).
Readings from the WBP chambers were captured every 2 seconds for the entire duration of exposure. Results were averaged for 20 minute intervals using the Finepointe system software (DSI, Minneapolis, MN).
Bronchoalveolar Lavage
Lungs were lavaged as detailed earlier (Romberger et al. 2002). Briefly, lungs were washed three times with 0.5 ml HBSS each time. Bronchioalveolar lavage (BAL) fluid was centrifuged at 1000 X g for 10 minutes, and supernatant transferred to new tubes and stored at -80oC. Cell pellets were resuspended in HBSS and stained with trypan blue (Life Technologies, Grand Island, NY) and counted using a hemocytometer. Cells were resuspended to 100 ul in HBSS and adhered to glass slides (Fisher Scientific; Pittsburgh, PA) via cytocentrifugation for 10 min at 10000 X g (Cytopin, Shandon Elliott, Great Britain). Cells were dried overnight and fixed and stained using Diff Quik kit (Siemens Healthcare Disagnostics, Newark, DE) and mounted using MM24 mounting media (Leica Biosystems; Buffalo Grove, IL). A differential count of 100 cells was made based on morphological assessment of cells and expressed as absolute cell numbers.
Lung collection
After BAL collection lungs were excised. The right lung was tied off at the primary bronchus, removed, flash frozen in liquid nitrogen, and stored at -80oC. The left lung was slowly inflated with 200 ul of 4% PFA (Sigma; St. Louis, MO) and stored in 4% PFA overnight, followed by 100% ethanol. The fixed lung was embedded the next day in paraffin in a Intelsint RVG/1 tissue processor (Intelsint; Turin, Italy) followed by mounting in paraffin blocks in Tissue Tek II tissue embedder (Sakura Finetek; Nagano, Japan).
Lung Histology
Lung sections from paraffin embedded lungs were sectioned in 5 uM slices on a Microm 350S microtome (Microm, Germany). Tissue sections were then stained with Hemotoxylin and Eosin as previously described (Rolls and Sampias 2019) and mounted using Surgipath MM24 (Leica Biosystems, Richmond, IL). Sections were imaged using an Aperio CS2 virutual microscopy system (Leica Biosystems, Concord ON Canada) and examined for any notable changes to lung structure.
ELISA
Quantification of MCP-1, MIP-2, IL-6, KC, IL-1b, TNF-a, IL-4, IL-5, IL-13, IL-33, and IL-10 in BAL fluid was determined by Luminex xMAP multiplex ELISA (Procartaplex, ThermoFisher) according to manufacturer’s specifications. Samples were read using a Bioplex 200 system (Bio-Rad, Hercules, California) and Bioplex Manager Software (Bio-Rad)
RNA purification and RT-PCR analysis
RNA was purified from lung tissue samples using a Qiagen RNeasy Plus Mini kit (Qiagen, Chatsworth CA) according to the manufacturer’s instructions for tissue extraction. Briefly, 20–25 mg of lung tissue was put into 350 ul of RLT lysis buffer and 2.0 mm zircon beads (BioSpec, Bartlesville, OK). Samples were placed in a Biospec Mini-BeadBeater-24 (BioSpec) and run twice for 2 minutes, with a pause between runs of 5 minutes where samples were held on ice to prevent heat buildup. Supernatant was removed to DNA eliminator column, and the remainder of purification done according to the kit protocol. RNA was quantified by Take3 plate (Biotek, Winooski, VT) in a Synergy HT plate reader (BioTek). cDNA synthesis was done using the iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad, Hercules, CA) with 300 ng of template mRNA. Samples were incubated at 25oC for 5 min, 46oC for 20 minutes, and finally at 95oC for 1 minute in a Bio-Rad CFX96 Touch Real-Time PCR Detection System (BioRad). RT-PCR was done using probes for TLR2 (Mm00442346_m1), TLR4 (Mm445273_m1), Hsp72 (Mm01159846_S1), A20/TNFAIP3 (Mm00437121_m1) (Life Technologies, Grand Island, NY). Ribosomal RNA (Life Technologies) was used as an endogenous control in all reactions. PCR was conducted using a Bio-Rad CFX96 Touch Real-Time PCR Detection System (Bio-Rad). Reactions were all carried out in duplicate and performed 2 minutes at 50oC, 10 minutes at 95oC, then 40 cycles of 15 seconds at 95oC and 1 at 60oC minute each using ddPCR Supermix for Probes kit (Bio-Rad). Relative comparison of selected targets to the ribosomal endogenous control cycle threshold (CT) value was analyzed with the DDCt method.
Statistical Analysis
Data was analyzed using GraphPad Prism 6 (GraphPad Software, San Diego, CA). Error bars represent mean +/- SEM. For values outside the assay limit of detection either the LOD/2 or a minimum value below the lowest attained value was designated. Statistical significance was determined using one-way ANOVA with follow-up Tukey test for multiple comparisons. If the assumption of equal variance was not met, the data was either log transformed followed by one-way ANOVA and multiple comparison tests, or nonparametric tests (Kruskal-Wallace) were conducted. For all tests, a p-value < = 0.05 was considered significant for differences between groups.